() chief executive officer Sean Hall tells Proactive Investors how the company is tapping into new areas of its “therapeutic toolkit” to better assist those with chronic health conditions.
Hall says there has been a shortfall in the standard of quality healthcare today and Medlab is looking to provide better new health solutions.
The company is doing extensive work exploring the role gut health plays in chronic illnesses and developing quality nutraceuticals, popular treatments that contributed towards Medlab's revenue milestones last month.
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
In exchange for publishing services rendered by the Company on behalf of Medlab Clinical Ltd named herein, including the promotion by the Company of Medlab Clinical Ltd in any Content on the Site, the Company...
FOR OUR FULL DISCLAIMER CLICK HERE